-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BRxBwBqV0ZAVxWnDXgQ/L9z+Tm8saAV0BAdBohJRB51RcADpMw+lNEmiCBcBet2r 766XD6/Ykii/8BQmeZGP0Q== 0000064670-07-000081.txt : 20071025 0000064670-07-000081.hdr.sgml : 20071025 20071025133448 ACCESSION NUMBER: 0000064670-07-000081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071023 FILED AS OF DATE: 20071025 DATE AS OF CHANGE: 20071025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ellis Gary Lee CENTRAL INDEX KEY: 0001290170 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 071190380 BUSINESS ADDRESS: BUSINESS PHONE: 763-514-4000 MAIL ADDRESS: STREET 1: MEDTRONIC, INC. STREET 2: 710 MEDTRONIC PARKWAY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 doc.xml PRIMARY DOCUMENT X0202 4 2007-10-23 0000064670 MEDTRONIC INC MDT 0001290170 Ellis Gary Lee MEDTRONIC, INC. 710 MEDTRONIC PARKWAY, M.S. LC310 MINNEAPOLIS MN 55432-5604 0 1 0 0 Sr VP & CFO Common Stock 2007-10-23 4 M 0 18552 21.5625 A 71659.855 D Common Stock 2007-10-23 4 F 0 3344 48.03 D 68315.855 D Common Stock 2007-10-23 4 F 0 8329 48.03 D 59986.855 D Common Stock 4034.583 I By 401(k) Plan Common Stock 6533.637 I By ESOP Stock Options (Right to buy) 21.5625 2007-10-23 4 M 0 18552 0 D 1998-10-29 2007-10-29 Common Stock 18552 0 D These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. James N. Spolar, Attorney-in-Fact 2007-10-25 -----END PRIVACY-ENHANCED MESSAGE-----